Close
  Indian J Med Microbiol
 

Figure 4: The effect of pretreatment of rats with Assafoetida on the incidence of irreversible ventricular fi brillation (a), infarct size (b) and creatine kinase (c) following 30 min global ischemia and 90 min reperfusion. Con, Control group; T25, T50 and T100 mean pretreatment of rats with oral doses of 25, 50 and 100 mg/kg of Assafoetida for four weeks before isolation of the heart. *P < 0.05 compared to the Con group

Figure 4: The effect of pretreatment of rats with Assafoetida on the incidence of irreversible ventricular fi brillation (a), infarct size (b) and creatine kinase (c) following 30 min global ischemia and 90 min reperfusion. Con, Control group; T25, T50 and T100 mean pretreatment of rats with oral doses of 25, 50 and 100 mg/kg of Assafoetida for four weeks before isolation of the heart. *<i>P</i> < 0.05 compared to the Con group